Cargando…
Estimated Versus Observed Expenditure Associated with Medicines Recommended by the All Wales Medicines Strategy Group
OBJECTIVES: The All Wales Medicines Strategy Group (AWMSG) appraises the clinical and cost effectiveness of new medicines being considered for National Health Service (NHS) prescribing in Wales (UK). The aim of this study was to compare the estimated expenditure on selected medicines submitted by ph...
Autores principales: | Keeping, Stuart, Deslandes, Paul N., Haines, Kathryn E., Routledge, Philip A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6710308/ https://www.ncbi.nlm.nih.gov/pubmed/30656545 http://dx.doi.org/10.1007/s41669-019-0116-5 |
Ejemplares similares
-
New Medicines in Wales: The All Wales Medicines Strategy Group (AWMSG) Appraisal Process and Outcomes
por: Varnava, Alice, et al.
Publicado: (2018) -
Medicines prescribed by non-medical independent prescribers in primary care in Wales: a 10-year longitudinal study April 2011–March 2021
por: Deslandes, Paul, et al.
Publicado: (2022) -
Costs of orphan medicinal products: longitudinal analysis of expenditure in Wales
por: Pijeira Perez, Yankier, et al.
Publicado: (2023) -
Changes in suspected adverse drug reaction reporting via the yellow card scheme in Wales following the introduction of a National Reporting Indicator
por: Deslandes, Paul N., et al.
Publicado: (2022) -
History of Medicine Society of Wales
Publicado: (1973)